Cargando…

P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)

Detalles Bibliográficos
Autores principales:	Kowanetz, M, Vu, MT, Wu, J, Koeppen, H, Kohrt, H, Gettinger, S, Cruz, C, Denker, M, Chen, DS, Hegde, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072139/ http://dx.doi.org/10.1186/2051-1426-2-S2-P4

Ejemplares similares

Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1
por: Kohrt, Holbrook, et al.
Publicado: (2013)

Circulating and tumor-based biomarkers predict clinical activity in cancer patients treated with the engineered anti-PD-L1 antibody MPDL3280A
por: Kowanetz, Marcin, et al.
Publicado: (2014)

Myeloid cell biology and inhibition of anti-tumor immune responses by MPDL3280A in urothelial bladder cancer
por: Xiao, Yuanyuan, et al.
Publicado: (2014)

Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)
por: Powles, Thomas, et al.
Publicado: (2015)

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
por: Cha, E
Publicado: (2014)

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
por: Carbognin, Luisa, et al.
Publicado: (2015)

Draft genome sequencing of the sugarcane hybrid SP80-3280
por: Riaño-Pachón, Diego Mauricio, et al.
Publicado: (2017)

3280 Mycobacterium bovis Bacille-Calmette-Guérin infection aggravates atherosclerosis
por: Huaman, Moises, et al.
Publicado: (2019)

Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
por: Fernández-Sainz, Jesús, et al.
Publicado: (2023)

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
por: Kowanetz, Marcin, et al.
Publicado: (2018)

A BAC library of the SP80-3280 sugarcane variety (saccharum sp.) and its inferred microsynteny with the sorghum genome
por: Figueira, Thais Rezende e Silva, et al.
Publicado: (2012)

LBODP030 A Rare Case Of Partial Lipodystrophy From Mpdl (mandibular Hypoplasia, Deafness, Progeroid, Lipodystrophy Syndrome) Due To Pold1 Gene Mutation
por: Majumdar, Sujoyeeta, et al.
Publicado: (2022)

Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab
por: Vennapusa, Bharathi, et al.
Publicado: (2019)

C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patients
por: Patil, Namrata S., et al.
Publicado: (2021)

In Vitro Engineering of Vascularized Tissue Surrogates
por: Sakaguchi, Katsuhisa, et al.
Publicado: (2013)

Molecular Targeting of the Oncoprotein PLK1 in Pediatric Acute Myeloid Leukemia: RO3280, a Novel PLK1 Inhibitor, Induces Apoptosis in Leukemia Cells
por: Wang, Na-Na, et al.
Publicado: (2015)

MAP kinase inhibitors stimulate T cell and anti-tumor activity in combination with blockade of the PD-L1/PD-1 interaction
por: Irving, Bryan A, et al.
Publicado: (2013)

Surrogate-based modeling and optimization: applications in engineering
por: Koziel, Slawomir, et al.
Publicado: (2013)

Engineering design via surrogate modelling : a practical guide
por: Forrester, Alexander I. J.
Publicado: (2008)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
por: Hughes, Jing, et al.
Publicado: (2015)

Feature Engineering for Surrogate Models of Consolidation Degree in Additive Manufacturing
por: Roy, Mriganka, et al.
Publicado: (2021)

Introductory statistics and random phenomena: uncertainty, complexity and chaotic behavior in engineering and science
por: Denker, Manfred, et al.
Publicado: (2017)

Impact of Multi-Component Surrogates on the Performances, Pollutants, and Exergy of IC Engines
por: Mondo, Kambale, et al.
Publicado: (2022)

Surrogates are just surrogates, but helpful just the same
por: Fabian, Carol
Publicado: (2007)

Intra-household agreement of urinary elemental concentrations in Tanzania and Kenya: potential surrogates in case-control studies
por: Middleton, Daniel R. S., et al.
Publicado: (2018)

Surrogate-based modeling and optimization : applications in engineering
Publicado: (2013)

Use of Mesothelial Cells and Biological Matrices for Tissue Engineering of Simple Epithelium Surrogates
por: Lachaud, Christian Claude, et al.
Publicado: (2015)

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
por: Banchereau, Romain, et al.
Publicado: (2021)

Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993)

Introductory statistics and random phenomena: uncertainty, complexity and chaotic behavior in engineering and science
por: Denker, Manfred, et al.
Publicado: (1998)

Formulation of 7-Component Surrogate Mixtures for Military Jet Fuel and Testing in Diesel Engine
por: Luning Prak, Dianne Jeanne, et al.
Publicado: (2022)

TGFβ induces SIK to negatively regulate type I receptor kinase signaling
por: Kowanetz, Marcin, et al.
Publicado: (2008)

Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

A surrogate FRAX model for Pakistan
por: Naureen, G., et al.
Publicado: (2021)

Closed-system behaviour of the intra-crystalline fraction of amino acids in mollusc shells
por: Penkman, K.E.H., et al.
Publicado: (2008)

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer
por: Dhodapkar, Kavita, et al.
Publicado: (2014)

Formation of Mixed-Ligand Complexes of Pd(2+) with Nucleoside 5'-Monophosphates and Some Metal-Ion-Binding Nucleoside Surrogates
por: Golubev, Oleg, et al.
Publicado: (2014)

PD13 - Gender differences in rhinitic children
por: Ferrante, Giuliana, et al.
Publicado: (2014)

The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005)

Surrogate Endpoints in Medicine
por: Srivastava, Sudhir, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_7uvmbu0auj6782o5attb8njhki